Actavis sells Chinese operations to Zhejiang Chiral Medicine
Executive Summary
Zhejiang Chiral Medicine Chemicals Co. Ltd. (APIs and intermediates, specializing in chiral pharmaceuticals) acquired Actavis PLC’s Chinese subsidiary Actavis (Foshan) Pharmaceutical Co. Ltd.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice